The Pan American Health Organization
Promoting Health in the Americas

 Safe Hospitals

Health Surveillance & Disease Prevention & Control — Communicable Diseases: 
Acute Respiratory Infections - Anthrax - Antimicrobial Resistance - Campylobacter - Chagas -
Cholera - Dengue - Diarrheal/Enteric Diseases - Disease Outbreak News -
Emerging/Reemerging Diseases - Filariasis - Hantavirus - InfluenzaAvian |  Pandemic |  Seasonal - International Health Regulations - Leishmaniasis - Leprosy - Malaria -
Neglected Diseases - Parasitic Diseases - Rabies - Research - Salmonella - Shigella - Smallpox -
Tuberculosis - West Nile Virus  - Yellow Fever  -
Health Analysis & Statistics - Chronic Diseases - Veterinary Public Health


EID Updates

EID Updates:

Emerging and Reemerging Infectious Diseases,
Region of the Americas

Vol. 5, No. 10 (27 March 2008)                             Main Updates index


Final Statement by PAHO/WHO on Investigation of Serious Adverse Events in Peru following Receipt of Yellow Fever Vaccine Produced by Bio-Manguinhos, Brazil

PAHO/WHO Immunization Unit

This PAHO/WHO statement provides results of the investigation of serious adverse events that occurred in October 2007 in Peru following administration of the yellow fever vaccine (substrain 17DD) manufactured by Bio-Manguinhos, Brazil. It contains the conclusions of the expert group as well as their recommendations.

A previous PAHO/WHO statement on the reported events was issued on 2 November 2007 and recommended temporary suspension of specific lots of the vaccine.

Source: PAHO/WHO Immunization Unit, Family and Community Health Area.